Skip to content
Apex Nursing

Chart — Renal

Dialysis Comparison Chart

Hemodialysis vs peritoneal dialysis — mechanism, access, frequency, advantages, limitations, and nursing considerations side-by-side for nursing students and NCLEX preparation.

Source: National Kidney Foundation KDOQI Guidelines; KDIGO 2022 CKD Guidelines; clinical nephrology references. Reflects standard practice — protocols vary by institution.

Educational use only. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.

Key teaching point: Neither hemodialysis nor peritoneal dialysis is universally superior — the choice depends on patient preference, cardiovascular stability, lifestyle, surgical history, and residual kidney function. Transplant remains the optimal treatment for ESRD when eligible.

Hemodialysis (HD)

Extracorporeal · 3× weekly · Vascular access required

Peritoneal Dialysis (PD)

Home-based · Continuous/overnight · Peritoneal catheter

FeatureHemodialysisPeritoneal Dialysis
MechanismExtracorporeal circuit — blood removed from body, filtered by artificial kidney (dialyzer/hemofilter), returned to patientBlood stays in the body — dialysate instilled into peritoneal cavity; peritoneum serves as natural semipermeable membrane
Primary principleDiffusion (concentration gradient) + ultrafiltration (hydrostatic pressure) across synthetic membraneDiffusion + osmosis (dextrose in dialysate creates osmotic gradient to remove fluid) across peritoneal membrane
Vascular accessRequired: AV fistula (preferred), AV graft, tunneled CVC, or temporary CVCPeritoneal catheter (Tenckhoff catheter) inserted into peritoneal cavity — exits through abdominal wall
SettingOutpatient dialysis center (most common) or in-hospital. In-center or home hemodialysis programs.Home-based primarily — CAPD (continuous) or APD (automated, overnight cycler). Hospital-based for acutely ill patients.
Frequency / scheduleConventional: 3 sessions/week × 3–5 hours each. Home HD: may be daily or more frequent.CAPD: 3–5 exchanges/day, 4–8 hours each dwell. APD: automated overnight cycler runs 8–10 hours nightly.
Fluid removalUltrafiltration — rapid, precise volume removal per session (1–3 L typical). Fluid restriction needed between sessions.Gradual, continuous fluid removal via osmosis. Less dramatic fluid shifts. Better for hemodynamically unstable.
Solute clearanceRapid, efficient small-solute clearance (urea, creatinine, K⁺). Higher weekly clearance for small molecules.Slower but continuous small-solute clearance. Better middle-molecule clearance (beta-2 microglobulin) in some cases.
Hemodynamic impactSignificant — rapid fluid shifts can cause intradialytic hypotension; less well tolerated in cardiovascular instabilityMinimal — gradual fluid removal; better tolerated in heart failure, hemodynamic instability, hypotension-prone patients
Cardiovascular patientsMore challenging in severe HF, low BP, hemodynamic instability — rapid fluid shifts stress the heartPreferred in patients with severe cardiovascular disease, hemodynamic instability, limited vascular access
AdvantagesMost efficient small-solute clearance; professional monitoring at center; rapid correction of hyperkalemia/acidosis; AV access long-termHome-based (independence, flexible schedule); no vascular access needed; continuous dialysis (more physiologic); better cardiovascular tolerance; preserves residual renal function longer
LimitationsVascular access complications; intradialytic hypotension; schedule inflexibility; requires travel 3×/week; hemodynamic stressPeritonitis risk; catheter site infections; technique failure; requires manual dexterity and cognitive ability; inadequate in large patients or after abdominal surgery
ContraindicationsNo reliable vascular access; severe coagulopathy (anticoagulation required); hemodynamic instability (relative)Recent abdominal surgery (within 2–4 weeks); abdominal adhesions (reduces membrane function); hernias; severe COPD/respiratory failure (diaphragmatic pressure); severe protein malnutrition; inability to perform exchanges
AnticoagulationSystemic heparin or regional citrate anticoagulation required to prevent circuit clottingNot required for dialysis itself — heparin may be added to dialysate to prevent fibrin clots in catheter
Infection risksVascular access infections (CVC > graft > fistula); potential for bloodborne pathogen exposure in centerPeritonitis (most serious complication); catheter exit site infection; tunnel infection — often from Staph aureus or coagulase-negative Staph
Protein lossMinimal protein loss through dialyzer (small amount of albumin)Significant protein loss through peritoneal membrane (6–12 g/day) → increased dietary protein requirements
Dietary requirementsRestrict K⁺, phosphorus, Na⁺, fluid between sessions. Adequate protein intake.Higher protein requirement (compensate for losses); lower potassium restriction typically possible; watch dextrose glucose absorption (glucose from dialysate absorbed — watch for hyperglycemia in diabetics)
Nursing considerationsAssess access patency (bruit/thrill); pre/post vital signs and weight; monitor for intradialytic hypotension; hold antihypertensives pre-dialysis; never use fistula arm for BP/IV/blood drawTeach sterile exchange technique; assess catheter exit site; monitor for signs of peritonitis (cloudy effluent, abdominal pain, fever); accurate measurement of instilled vs drained volumes; daily weight

Peritonitis Warning Signs (PD Patients)

Peritonitis is the most serious complication of peritoneal dialysis — requires urgent treatment

Cloudy effluent

Most reliable early sign — turbid PD drainage = peritonitis until proven otherwise

Abdominal pain / tenderness

Diffuse or localized; may be severe

Fever

Temperature >37.5°C with other signs = urgent evaluation

Nausea / vomiting

GI symptoms accompany abdominal peritoneal irritation

Action: Send cloudy effluent for cell count, differential, culture. Empiric antibiotics per protocol. Do NOT delay treatment.

Related Resources

Standards & sources

Fact-checked Jun 21, 2026

This page is written to align with National Kidney Foundation KDOQI Guidelines; KDIGO 2022 CKD Guidelines. It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →